BMY vs RIME · P/E 17, rev $24.46B vs rev $5.4M
Bristol-Myers Squibb Company (BMY) versus Algorhythm Holdings, Inc. (RIME) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Algorhythm Holdings, Inc. (RIME) is a consumer electronics company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported RIME revenue for 2026-06-30 was $5.4M. Net income was -$8.9M. RIME currently screens at market cap $11.6M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. RIME currently screens at market cap $11.6M.
Not investment advice. Open the BMY and RIME stock pages for the full models.
Not investment advice.